MammoRisk: A Novel Tool for Assessing Breast Cancer Risk MammoRisk: A Novel Tool for Assessing Breast Cancer Risk
A software tool based on machine learning may contribute to the early diagnosis and treatment of breast cancer, which could help decrease overall healthcare costs for society.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Ob/Gyn & Women ' s Health News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Healthcare Costs | Learning | Pathology | Universities & Medical Training | Women